• Study on Azacitidine and Gilteritinib for Adults with Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Continued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib

    Not recruiting

    2 1 1
    Investigated Drugs:
    Austria Belgium Germany Greece Italy Spain
  • Study of 68Ga Satoreotide Trizoxetan PET/CT in Patients with High-Grade Neuroendocrine Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Denmark
  • Study on the Effects of GLPG3667 for Adults with Dermatomyositis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Croatia Czechia France Germany +4
  • Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Denmark Finland France Hungary +7
  • Study on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Italy The Netherlands Poland +2
  • Study on PRAX-562 for Children with Developmental and Epileptic Encephalopathies

    Not recruiting

    2 1
    Spain
  • Study on Hydroxycarbamide Resistance in Patients with Polycythemia Vera Identified by AI Predictors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of CFT1946 alone and with trametinib or cetuximab in patients with BRAF-V600 mutant solid tumors who have received standard treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France Germany Italy Spain
  • Study on the Safety and Effects of RBD1016 Injection for Patients with Chronic Hepatitis B on Nucleoside Analogues Treatment

    Not recruiting

    2 1
    Investigated Drugs:
    Sweden

powered by